Cargando…

Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri

KPC-82 is a KPC-2 variant identified in a carbapenem-nonsusceptible Citrobacter koseri that confers high-level resistance to ceftazidime-avibactam. Genomic analysis revealed that bla(KPC-82) is carried by a chromosomally integrated Tn4401 transposon (disrupting porin gene phoE) and evolved by a 6-nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebreton, Francois, Corey, Brendan W., McElheny, Christi L., Iovleva, Alina, Preston, Lan, Margulieux, Katie R., Cybulski, Robert J., Mc Gann, Patrick, Doi, Yohei, Bennett, Jason W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218621/
https://www.ncbi.nlm.nih.gov/pubmed/33972237
http://dx.doi.org/10.1128/AAC.00150-21
_version_ 1783710797547962368
author Lebreton, Francois
Corey, Brendan W.
McElheny, Christi L.
Iovleva, Alina
Preston, Lan
Margulieux, Katie R.
Cybulski, Robert J.
Mc Gann, Patrick
Doi, Yohei
Bennett, Jason W.
author_facet Lebreton, Francois
Corey, Brendan W.
McElheny, Christi L.
Iovleva, Alina
Preston, Lan
Margulieux, Katie R.
Cybulski, Robert J.
Mc Gann, Patrick
Doi, Yohei
Bennett, Jason W.
author_sort Lebreton, Francois
collection PubMed
description KPC-82 is a KPC-2 variant identified in a carbapenem-nonsusceptible Citrobacter koseri that confers high-level resistance to ceftazidime-avibactam. Genomic analysis revealed that bla(KPC-82) is carried by a chromosomally integrated Tn4401 transposon (disrupting porin gene phoE) and evolved by a 6-nucleotide tandem repeat duplication causing a two-amino-acid insertion (Ser-Asp) within the Ala(267)-Ser(275) loop. Similar to related KPC variants, KPC-82 showed decreased carbapenemase activity when expressed in a heterologous background and remained susceptible to carbapenem/β-lactamase inhibitor combinations.
format Online
Article
Text
id pubmed-8218621
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-82186212021-12-17 Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri Lebreton, Francois Corey, Brendan W. McElheny, Christi L. Iovleva, Alina Preston, Lan Margulieux, Katie R. Cybulski, Robert J. Mc Gann, Patrick Doi, Yohei Bennett, Jason W. Antimicrob Agents Chemother Mechanisms of Resistance KPC-82 is a KPC-2 variant identified in a carbapenem-nonsusceptible Citrobacter koseri that confers high-level resistance to ceftazidime-avibactam. Genomic analysis revealed that bla(KPC-82) is carried by a chromosomally integrated Tn4401 transposon (disrupting porin gene phoE) and evolved by a 6-nucleotide tandem repeat duplication causing a two-amino-acid insertion (Ser-Asp) within the Ala(267)-Ser(275) loop. Similar to related KPC variants, KPC-82 showed decreased carbapenemase activity when expressed in a heterologous background and remained susceptible to carbapenem/β-lactamase inhibitor combinations. American Society for Microbiology 2021-06-17 /pmc/articles/PMC8218621/ /pubmed/33972237 http://dx.doi.org/10.1128/AAC.00150-21 Text en Copyright © 2021 Lebreton et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mechanisms of Resistance
Lebreton, Francois
Corey, Brendan W.
McElheny, Christi L.
Iovleva, Alina
Preston, Lan
Margulieux, Katie R.
Cybulski, Robert J.
Mc Gann, Patrick
Doi, Yohei
Bennett, Jason W.
Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title_full Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title_fullStr Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title_full_unstemmed Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title_short Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
title_sort characterization of kpc-82, a kpc-2 variant conferring resistance to ceftazidime-avibactam in a carbapenem-nonsusceptible clinical isolate of citrobacter koseri
topic Mechanisms of Resistance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218621/
https://www.ncbi.nlm.nih.gov/pubmed/33972237
http://dx.doi.org/10.1128/AAC.00150-21
work_keys_str_mv AT lebretonfrancois characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT coreybrendanw characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT mcelhenychristil characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT iovlevaalina characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT prestonlan characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT margulieuxkatier characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT cybulskirobertj characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT mcgannpatrick characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT doiyohei characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri
AT bennettjasonw characterizationofkpc82akpc2variantconferringresistancetoceftazidimeavibactaminacarbapenemnonsusceptibleclinicalisolateofcitrobacterkoseri